يعرض 1 - 20 نتائج من 71 نتيجة بحث عن '"resistance to chemotherapy"', وقت الاستعلام: 0.61s تنقيح النتائج
  1. 1
    Conference
  2. 2
    Academic Journal
  3. 3
    Academic Journal

    المساهمون: Institut de Chimie de Nice (ICN), Université Nice Sophia Antipolis (1965 - 2019) (UNS)-Institut de Chimie - CNRS Chimie (INC-CNRS)-Centre National de la Recherche Scientifique (CNRS)-Université Côte d'Azur (UniCA), Institut de pharmacologie moléculaire et cellulaire (IPMC), Université Nice Sophia Antipolis (1965 - 2019) (UNS)-Centre National de la Recherche Scientifique (CNRS)-Université Côte d'Azur (UniCA), Università degli Studi di Cagliari = University of Cagliari (UniCa), G.M. and P. R. acknowledge support by National Institute of Allergy and Infectious Diseases/NIH grant no. R01AI136799., Région PACA, ANR-15-IDEX-0001,UCA JEDI,Idex UCA JEDI(2015), European Project: 847581,H2020,H2020-MSCA-COFUND-2018,BoostUrCAreer(2019)

    المصدر: ISSN: 0223-5234.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/35421658; info:eu-repo/grantAgreement//847581/EU/Boosting PhD employability @UCA/BoostUrCAreer; hal-03845877; https://hal.science/hal-03845877; https://hal.science/hal-03845877/document; https://hal.science/hal-03845877/file/Review-EJMC_revised2.pdf; PUBMED: 35421658

  4. 4
    Academic Journal
  5. 5
    Academic Journal

    المؤلفون: Villa C., Chaplain M. A. J., Lorenzi T.

    المساهمون: Villa, C., Chaplain, M. A. J., Lorenzi, T.

    وصف الملف: ELETTRONICO

    Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000576130300001; volume:49; firstpage:143; lastpage:167; numberofpages:25; journal:VIETNAM JOURNAL OF MATHEMATICS; http://hdl.handle.net/11583/2870764

  6. 6
    Academic Journal

    المصدر: International Journal of Molecular Sciences; Volume 22; Issue 22; Pages: 12404

    جغرافية الموضوع: agris

    وصف الملف: application/pdf

    Relation: Molecular Oncology; https://dx.doi.org/10.3390/ijms222212404

  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal

    المؤلفون: Anil Mishra

    المصدر: Int. J. Basic Clin. Immonol, 3(1-4), 1-8, (2020-12-22)

    مصطلحات موضوعية: Objectives: Pancreatic malignancy is a major public health problem worldwide and recent reports indicated that pancreatic cancer will be second most common cause of cancer-related deaths by the end of 2021. The cause of increasing death rate is due to the nonexistence of detection tools to early diagnose, poor prognosis, resistance to chemotherapy and also lack in understanding the mechanism of PDAC pathogenesis. Circulating tumor cells (CTCs) play a major role in metastatic step of intravasation and presence of these cells are strong prognostic marker for the progression of pancreatic malignancy in chronic pancreatitis (CP). Goal: Identifying the novel CTCs in the chronic inflammation mediated experimental model for the progression of malignancy in CP. Methods: We have performed flow cytometer and immunofluorescence analyses were performed in the lymphoid and lung samples to detect CTCs in the chronic inflammation (Cerulin and Azoxymethane) induced CP mouse model. Results: We report that induced SOX9 positive cells were observed in the blood, lymph node and spleen samples of cerulein with azoximethane (AOM) treated mice compared to cerulein alone. Further, we provide evidence that early metastasis through the migration and homing of mega merged SOX9+ and PDX+ ductal stem cells (CTCs) in the lungs of cerulein with AOM treated mice. These identified CTCs in experimentally induced malignant pancreatitis may serve as a novel finding to identify a non-invasive biomarker that needs to be examined in the blood of human pancreatic cancer. Conclusions: Taken together, the presented data of identified mega merged SOX9+ and PDX+ ductal stem cells (CTCs) may serve a non-invasive biomarker for the early detection of pancreatic malignancy and metastasis

    Relation: https://doi.org/10.1076/iJbCI.ISP; oai:zenodo.org:4386111

  10. 10
    Academic Journal
  11. 11
    Academic Journal

    المساهمون: Ministerio de Economía y Competitividad (España), Swiss National Science Foundation

    Relation: #PLACEHOLDER_PARENT_METADATA_VALUE#; info:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/BFU2016‐75319‐R; info:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/BFU2014‐51823‐R; Postprint; https://doi.org/10.1016/j.chembiol.2017.05.016; Sí; Cell Chemical Biology 24 (6) 737–750.e6 (2017); http://hdl.handle.net/10261/152590; http://dx.doi.org/10.13039/501100003329

  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
    Academic Journal
  17. 17

    المؤلفون: Ni Liu, Dan Pi, Chun-Mei Liu

    المصدر: Journal of Hainan Medical University, Vol 24, Iss 01, Pp 5-8 (2018)

    مصطلحات موضوعية: GRP78, endocrine system diseases, 409000. Fund Project: Science and Technology Project of Qianjiang District No: 2016056. 1. Introduction Ovarian cancer is one of the most common malignant tumors in the female reproductive system. Surgical resection and chemotherapy are the main treatments. Because ovarian cancer cells are more sensitive to chemotherapy drugs, Proliferation, DMEM, RIPA lysate was purchased in Shanghai Beyotime Company, lcsh:Medicine, Invasion, Chongqing, Ovarian cancer, especially platinum drugs, and enzyme-linked immunosorbent assay kits were purchased from Shanghai Westang Biotechnology Company. Objective: To study the effect of metformin combined with cisplatin on the expression of genes related to ovarian cancer cell growth and invasion in vitro. Methods: SKOV3 ovarian cancer cell lines were cultured and randomly divided into the control group treated with serumfree DMEM, the platinum-based intravenous chemotherapy is widely used in the treatment of advanced ovarian cancer[1, CyclinD1, the MET group treated with serum-free DMEM containing 10 mmol/L metformin and the DDP+MET group treated with serum-free DMEM containing 10 μmol/L cisplatin and 10 mmol/L metformin. Results: 24 h after treatment, some patients with ovarian cancer can develop drug resistance during chemotherapy, lcsh:R, TBX2, it has been confirmed in recent years that it has anti-tumor effect and chemotherapy drug sensitization effect, the growth and invasion of cancer cells involve the changes in the expression of multiple proliferationrelated genes and invasion-related genes. In the following studies, Metformin, the DDP group treated with serum-free DMEM containing 10 μmol/L cisplatin, Department of Obstetrics and Gynecology, which will affect the efficacy of chemotherapy[3]. Metformin is a kind of insulin sensitizer for diabetes treatment, Ki-67, Chongqing Qianjiang National Hospital, and its combination with a variety of chemotherapy drugs can enhance the killing effect of chemotherapy drugs on tumor cells[4]. In the progression of the course of ovarian cancer, Cisplatin, we specifically analyzed the effects of metformin combined with cisplatin on the expression of genes associated with ovarian cancer cell growth and invasion in vitro. 2. Experimental materials and methods 2.1 Experimental materials Ovarian cancer SKOV3 cell lines were bought in the cell bank of Chinese Academy of Sciences, fetal bovine serum and 0.125% trypsin for cell culture were purchased in Hyclone Company, cisplatin and metformin were bought in the Sigma Company

  18. 18
  19. 19
  20. 20